Showing results (71-80 of 738) with videos related to
Sort By:
Pageof 74
Current Opinion in Structural Biology|March 10, 2022
Structural bases of T cell antigen receptor recognition in celiac diseaseLaura Ciacchi, Hugh H Reid, Jamie RossjohnImmunology and Cell Biology|January 15, 2014
The Ly49 natural killer cell receptors: a versatile tool for viral self-discriminationRichard Berry, Jamie Rossjohn, Andrew G BrooksThe Journal of Biological Chemistry|August 13, 2021
Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike proteinPriyanka Chaurasia, Thi H O Nguyen, Louise C Rowntree, et al.Proceedings of the National Academy of Sciences of the United States of America|May 15, 2020
The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell functionPhilippa M Saunders, Bruce J MacLachlan, Phillip Pymm, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 27, 2026
Ellagic acid metabolism as a source of dietary MR1 ligandsDavid O'Sullivan, Carl J H Wang, Jeffry S Tang, et al.The Journal of Experimental Medicine|November 6, 2013
A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritisStephen W Scally, Jan Petersen, Soi Cheng Law, et al.Immunity|October 16, 2012
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac diseaseSophie E Broughton, Jan Petersen, Alex Theodossis, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivoAndrew I Webb, Michelle A Dunstone, Nicholas A Williamson, et al.Frontiers in Immunology|March 7, 2020
Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8+ T Cell ReceptorsLouise C Rowntree, Heleen van den Heuvel, Jessica Sun, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejectionLauren K Ely, Katherine J Green, Travis Beddoe, et al.Pageof 74